PLUS1
2.67
0.38 (16.59%)
0.38 (16.59%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 138,107 |
|
|||||
| News | - | ||||||
| Day High | 2.50 | Low High |
|||||
| Day Low | 2.29 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Codiak BioSciences Inc | CDAK | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.38 | 16.59% | 2.67 | 19:46:49 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.29 | 2.29 | 2.50 | 2.39 | 2.29 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,206 | 138,107 | $ 2.39 | $ 329,843 | - | 2.21 - 21.1471 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:46:49 | 5 | $ 2.50 | USD |
Period:
Draw Mode:
Codiak BioSciences Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 60.51M | 22.66M | 12.80M | $ 22.94M | $ -13.35M | -1.68 | -2.80 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 283.00k | 2.40% |
Codiak BioSciences News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CDAK Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.59 | 2.65 | 2.25 | 2.36 | 134,739 | 0.08 | 3.09% |
| 1 Month | 2.90 | 3.00 | 2.25 | 2.52 | 94,004 | -0.23 | -7.93% |
| 3 Months | 3.45 | 4.25 | 2.21 | 3.08 | 164,934 | -0.78 | -22.61% |
| 6 Months | 5.06 | 7.15 | 2.21 | 3.84 | 153,626 | -2.39 | -47.23% |
| 1 Year | 20.25 | 21.1471 | 2.21 | 6.64 | 123,397 | -17.58 | -86.81% |
| 3 Years | 14.10 | 37.85 | 2.21 | 12.99 | 160,002 | -11.43 | -81.06% |
| 5 Years | 14.10 | 37.85 | 2.21 | 12.99 | 160,002 | -11.43 | -81.06% |
Codiak BioSciences Description
| Codiak BioSciences Inc is a development-stage biopharmaceutical company focused on the development of exosome-based therapeutics for the treatment of a wide spectrum of diseases with high unmet medical need. The company have utilized engEx Platform to generate a pipeline of engineered exosomes, aimed at treating a broad range of diseases, including oncology, neuro-oncology, neurology, neuromuscular disease, infectious disease and rare disease. |
